Classic Biotech And Exports Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
as on 12-12-2024
- Paid Up Capital ₹ 5.00 Cr
as on 12-12-2024
- Company Age 30 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 12-12-2024
- Revenue %
(FY 2018)
- Profit 15868.24%
(FY 2018)
- Ebitda 15868.24%
(FY 2018)
- Net Worth 6.00%
(FY 2018)
- Total Assets -83.79%
(FY 2018)
About Classic Biotech And Exports
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹2.00 Cr.
Sri Lakshmi, Ramasita Nadimpally, Penmetsa Padmavathi, and One other member serve as directors at the Company.
- CIN/LLPIN
U51215TG1994PLC017673
- Company No.
017673
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jun 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationNa, Telangana
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Classic Biotech And Exports?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sri Lakshmi  | Director | 25-Feb-2004 | Current |
| Ramasita Nadimpally | Director | 08-Jun-1994 | Current |
| Penmetsa Padmavathi | Director | 01-Apr-1995 | Current |
| Jagannadha Penmetsa | Director | 01-Apr-1995 | Current |
Financial Performance of Classic Biotech And Exports.
Classic Biotech And Exports Ltd,, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 15868.24% increase in profit. The company's net worth moved up by a moderate rise of 6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Classic Biotech And Exports?
In 2018, Classic Biotech And Exports had a promoter holding of 30.26% and a public holding of 69.75%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 31 Jul 1996 | ₹2.00 Cr | Open |
How Many Employees Work at Classic Biotech And Exports?
Unlock and access historical data on people associated with Classic Biotech And Exports, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Classic Biotech And Exports, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Classic Biotech And Exports's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
